Background: Heart transplantation in teenagers has not been well studied. Teenage recipients have unique considerations that influence outcomes-complexity of cardiac disease, wide range of donor sizing and age, mechanical support options, and medication nonadherence. We sought to analyze the outcomes of heart transplantation in teenagers, focusing on sex-based disparities.
Methods: The United Network for Organ Sharing dataset was queried for patients 13 to 19 years of age who underwent heart transplantation from 2002 to 2021. Patients were divided into two groups based on sex. Baseline clinical characteristics were compared, along with an analysis of survival data. The primary outcome of interest was freedom from death or retransplantation.
Results: Heart transplantation was performed in 2320 teenagers; 812 (35.0%) were female. Female recipients were smaller (54.0 vs. 62.0 kg, p < 0.0001) and less likely to have congenital heart disease (26.5 vs. 31.6%, p < 0.0001). Female patients also had fewer pre-transplant ventricular assist devices (24.7 vs. 32.2%, p = 0.0002). By multivariable analysis, female sex was independently associated with lower survival (HR 1.26 [CI 1.08-1.48], p = 0.003). Sex-mismatched female recipients had significantly lower survival than sex-matched male recipients (HR 1.29 [CI 1.06-1.58], p = 0.009). Donor: recipient age difference < 5 years and donor: recipient weight > 1.2 were independent predictors of higher survival (p < 0.05).
Conclusions: Female teenagers have lower survival following heart transplantation than their male counterparts. Male donor-female recipient transplants have the lowest survival among sex-matching groups. The use of organs from oversized or younger donors in teenagers may be considered to help improve post-transplant survival.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/petr.70064 | DOI Listing |
Transplantation
November 2024
Division of Nephrology, University of Arizona, Tucson, AZ.
Background: The 2018 revision of the adult Heart Allocation Policy (aHAP) led to a notable increase in the rate of simultaneous heart-kidney transplants (SHKT) in the United States. However, this policy has faced criticism for its inability to enhance post-transplant survival rates or decrease mortality among SHKT recipients on the waitlist, although high-quality kidneys are used.
Methods: We analyzed data from the Organ Procurement and Transplantation Network, covering 1549 SHKT cases from 2015 to 2021.
Heart Fail Rev
March 2025
Department of Internal Medicine, MedStar Union Memorial Hospital Baltimore, Baltimore, MD, USA.
Cirrhotic cardiomyopathy (CCM) is a cardiac dysfunction linked to chronic liver disease, primarily characterized by impaired cardiac response to stress, despite normal baseline function. It presents with both systolic and diastolic dysfunction, along with electrophysiological changes such as QT interval prolongation. CCM is driven by a combination of systemic inflammation, nitric oxide-induced vasodilation, and neurohormonal dysregulation, leading to myocardial impairment and abnormal vascular responses.
View Article and Find Full Text PDFNat Commun
March 2025
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Hastings Center for Pulmonary Research, University of Southern California, Los Angeles, CA, USA.
Mucociliary clearance is a vital defense mechanism of the human airways, protecting against harmful particles and infections. When this process fails, it contributes to respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma. While advances in single-cell transcriptomics have revealed the complexity of airway composition, much of what we know about how airway structure impacts clearance relies on animal studies.
View Article and Find Full Text PDFNephrology (Carlton)
March 2025
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Background: The rising growth of patients with end-stage kidney disease (ESKD) associated with chronic liver disease (CLD) and refractory chronic heart failure (CHF) associated with advanced chronic kidney disease (CKD) complicated by ascites presents serious renal replacement therapy (RRT) challenges. Haemodialysis is often poorly tolerated owing to increased hemodynamic instability, bleeding, and encephalopathy risks. Peritoneal dialysis (PD) has emerged as a promising alternative, but its adoption and efficacy are not consistently supported by existing literature, and there lacks guideline consensus.
View Article and Find Full Text PDFKardiol Pol
January 2025
Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!